MPM Asset Management LLC
- SEC CIK
- 0001263048
- Latest filing
- Nov 14, 2025
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 5
- −1 vs. Q1 2025
- Portfolio value
- $43.3M
- −$26.1M (−37.6%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TRDAEntrada Therapeutics, Inc. | COM | 4,381,062 | $29.4M | 67.9% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 682,376 | $6.50M | 15.0% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 4,309,860 | $4.70M | 10.8% | 00.0% | Unchanged | History |
| RPTXRepare Therapeutics Inc. | COM | 1,121,318 | $1.56M | 3.6% | 00.0% | Unchanged | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 4,809,677 | $1.15M | 2.7% | −526,038−9.9% | Reduced | History |
Sold out since Q1 2025 (1)
Positions held at the end of Q1 2025 that are gone from this filing.